Gilead Sciences, Inc. (GILD) Tops Q2 EPS by 4c
Tweet
Share
E-mailGet Alerts GILD Hot Sheet
Price: $136.77 +0.66%
Financial Fact:
Selling, general and administrative: 831M
Today's EPS Names:
OFLX, VAXX, NMRD, More
Financial Fact:
Selling, general and administrative: 831M
Today's EPS Names:
OFLX, VAXX, NMRD, More
Join SI Premium – FREE
Gilead Sciences, Inc. (NASDAQ: GILD) reported Q2 EPS of $0.99, $0.04 better than the analyst estimate of $0.95. Revenue for the quarter came in at $2.41 billion versus the consensus estimate of $2.29 billion.
For earnings history and earnings-related data on Gilead Sciences, Inc. (GILD) click here.
For earnings history and earnings-related data on Gilead Sciences, Inc. (GILD) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Jefferies sees a buying opportunity in this S&P 500 sector
- Benchmark Reiterates Buy Rating on Jumia Technologies (JMIA)
- Boxlight Corporation (BOXL) Tops Q2 EPS by 2050c
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
